Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:53.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 is added to the page. A large set of study documents and related items, including Informed Consent Form entries and the Study Protocol/SAP, were removed from the Study Documents section.
    Difference
    18%
    Check dated 2026-09-20T19:25:39.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a small release version update.
    Difference
    0.1%
    Check dated 2026-08-30T15:38:06.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces the previous v3.6.4 in the page's revision line. This represents a minor update to the study record without changes to the trial design, results, or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-08-09T09:16:24.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a minor update to the page template or rendering.
    Difference
    0.1%
    Check dated 2026-07-25T17:37:54.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, indicating a new version of the page. This typically accompanies minor content or metadata updates rather than changes to the trial data.
    Difference
    0.1%
    Check dated 2026-07-04T04:46:43.000Z thumbnail image

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.